BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 1137370)

  • 1. Activity of cefazolin against dense populations of enterobacteria.
    Greenwood D; Chan-Teoh CH; O'Grady F
    Antimicrob Agents Chemother; 1975 Feb; 7(2):191-5. PubMed ID: 1137370
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Beta lactamase resistance of newer cephalosporins and antimicrobial effectiveness against gram-negative bacilli.
    Farrar WE; O'Dell NM
    Infection; 1977; 5(4):224-7. PubMed ID: 413793
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of in vitro antimicrobial activity of cefamandole and cefazolin with cephalothin against over 8,000 clinical bacterial isolates.
    Jones RN; Fuchs PC
    Antimicrob Agents Chemother; 1976 Jun; 9(6):1066-9. PubMed ID: 938021
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antimicrobial evaluation of cefoxitin: a new semisynthetic cephamycin. Comparative studies with cefazolin and cefalotin.
    Une T; Mitsuhashi S
    Arzneimittelforschung; 1977; 27(1):89-93. PubMed ID: 576821
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Susceptibility to first-generation Cephalosporins in Enterobacteriaceae isolated from urine culture according to CLSI and EUCAST breakpoints].
    Corvalán V; Hervé B; Sanhueza C; Martínez N; Almonacid M; Fuente S
    Rev Chilena Infectol; 2018; 35(3):329-331. PubMed ID: 30534916
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Another look at differences in the susceptibility of Escherichia coli and Klebsiella pneumoniae to cephalothin and cefazolin.
    Yeh LL; Chi CL
    Int J Antimicrob Agents; 2001 Jun; 17(6):521-4. PubMed ID: 11397625
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Microbiological evaluation of cefoxitin, a new beta-lactamase resistant cephamycin antibiotic, compared to cephalothin, cephaloridine and cefazolin].
    Schassan HH; Bentfeld G
    Fortschr Med; 1978 Aug; 96(30):1510-7. PubMed ID: 669547
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The in vitro activity of ceftezol (demethylcefazolin) against dense populations of Escherichia coli.
    Greenwood D; O'Grady F
    J Antibiot (Tokyo); 1976 May; 29(5):579-83. PubMed ID: 783103
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationships between in vitro susceptibility and efficacy in experimental mouse infection-protection assay of cefazolin and cephalothin using Escherichia coli strains.
    Uri JV; Actor P; Phillips L; Guarini JR; Weisbach JA
    Chemotherapy; 1976; 22(5):313-8. PubMed ID: 780071
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of antibacterial activities of cephalosporin antibiotics: cefazolin, cephaloridine, cephalothin, and cephalexin.
    Hsieh WC; Ho SW
    Zhonghua Min Guo Wei Sheng Wu Xue Za Zhi; 1975 Mar; 8(1):1-11. PubMed ID: 1097210
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro activity of BL-s640 against gram-negative bacilli and Staphylococcus aureus compared with activity of four other semisynthetic cephalosporins.
    Vuye A; Pijck J; Soep H
    Antimicrob Agents Chemother; 1976 Mar; 9(3):422-32. PubMed ID: 1259401
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Resistance categories of enterobacteria to beta-lactam antibiotics.
    Greenwood D; O'Grady F
    J Infect Dis; 1975 Sep; 132(3):233-40. PubMed ID: 1041500
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro susceptibility of Yersinia kristensenii strains to beta-lactam antibiotics.
    Bejar V; Calvo C; Ramos Cormenzana A
    Ann Inst Pasteur Microbiol (1985); 1986; 137A(2):169-77. PubMed ID: 3501272
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Beta-lactamase production and resistance to beta-lactam antibiotics in Nocardia.
    Wallace RJ; Vance P; Weissfeld A; Martin RR
    Antimicrob Agents Chemother; 1978 Nov; 14(5):704-9. PubMed ID: 310280
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Response of ampicillin resistant Escherichia coli to cephalosporins in an in vitro model simulating conditions of bacterial growth in the urinary bladder.
    Greenwood D; O'Grady F
    Br J Exp Pathol; 1975 Apr; 56(2):167-71. PubMed ID: 1106751
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HR 756, the syn isomer of a new methoxyimino cephalosporin with unusual antibacterial activity.
    Chabbert YA; Lutz AJ
    Antimicrob Agents Chemother; 1978 Nov; 14(5):749-54. PubMed ID: 31836
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Susceptibility of clinical isolates of Enterobacteriaceae to BL-S640, a new oral cephalosporin.
    Watanakunakorn C; Bannister T; Glotzbecker C
    Antimicrob Agents Chemother; 1975 Mar; 7(3):381-5. PubMed ID: 1137392
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Microbiological activity of cefazedone as compared to cefazolin and cephalothin.
    Knothe H
    Arzneimittelforschung; 1979; 29(2a):378-81. PubMed ID: 39575
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of cefotiam and cefazolin activity against Gram-negative bacilli.
    Ogawa M; Hama M; Kosaki G; Shimatani M; Suginaka H
    J Antimicrob Chemother; 1979 Nov; 5(6):681-5. PubMed ID: 395155
    [No Abstract]   [Full Text] [Related]  

  • 20. Comparison of the antibacterial activity of nine cephalosporins against Enterobacteriaceae and nonfermentative gram-negative bacilli.
    Verbist L
    Antimicrob Agents Chemother; 1976 Oct; 10(4):657-63. PubMed ID: 984801
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.